Loading
Our Pre-Formulation Services evaluate the developability of molecules at the earliest stage of pharmaceutical development.
By characterizing the physical, chemical, and mechanical properties of new drug substances, we help identify
potential challenges such as solubility, stability, and bioavailability and define clear strategies
for efficient downstream development.
At Sortis Pharma, our pre-formulation capabilities are designed to deliver comprehensive profiling of molecules to
support formulation design and development planning. Our advanced laboratories perform detailed assessments that
help you save time, reduce material waste, and make data-driven decisions for future stages of development

Our scientific team performs structured evaluations of key material attributes, including:
This early characterization helps identify risks and establish a strong scientific foundation for formulation and process development.
Our solid-state experts focus on addressing performance issues related to polymorphism, crystal form, and material properties that can affect stability and manufacturability. Services include:
Choosing the right solid form early drives better stability, process performance, and bioavailability in later stages.

To support a broad range of development goals, we also offer tailored formulation strategies that complement pre-formulation insights. These include approaches designed to enhance bioavailability or support specific delivery routes such as:
All formulation solutions are planned with scalability in mind, ensuring a smooth transition from lab to clinical stages.

Pre-formulation studies provide critical insight into the physicochemical behavior of drug substances, supporting informed formulation decisions.

Early characterization data helps define appropriate formulation approaches, process feasibility, and development pathways.

Structured pre-formulation activities support data integrity, documentation quality, and alignment with development expectations.
Identifying potential challenges early helps reduce development risk, minimize rework, and support efficient progression.
Let’s discuss how our pharmaceutical capabilities can support your requirements.